Timothy M. Mayleben, President & CEO at Esperion Therapeutics, Inc. (ESPR), bought 10,000 shares at $48.73 ($487K) on 2019-03-14, disclosed to the SEC on 2019-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.73 | 5,000 | $244K | 50.0% |
| 2 | $48.73 | 5,000 | $244K | 50.0% |
| Total | $48.73 avg | 10,000 | $487K | 100% |
| Filing → |
| ESPR | BUY | 2019-11-08 | $370K | — | Filing → |
| ESPR | BUY | 2019-09-06 | $259K | — | Filing → |
| ESPR | BUY | 2019-08-02 | $198K | — | Filing → |